In the treatment of Alzheimer disease (AD), drugs such as cholinesterase inhibitors (ChEIs) are widely prescribed because they offer hope of symptom relief and place a low adherence burden on people living with AD and their caregivers. The gene discussed is BCHE; the disease is Alzheimer disease.